Adult T-Cell Leukemia/Lymphoma in London: Clinical Experience of 21 Cases

References

• Yamaguchi K. HTLV-1 in Japan. Lancet 1994; 343: 213–215
   PubMed Web of Science ®Google Scholar
• Manns A., Cleghorn F.R., Falk R.T., Hanchard B., Jaffe E.S., Bartholomew C., Hartge P., Benichou J., Blattner W.A., HTLV Lymphoma Study Group. Role of HTLV-I in development of non-Hodgkin lymphoma in Jamaica and Trinidad and Tobago. Lancet 1993; 342: 1447–1450
   PubMed Web of Science ®Google Scholar
• Catovsky D., Greaves M.F., Rose M., Galton D.A., Goolden A.W., McCluskey D.R., White J.M., Lampert I., Bourikas G., Ireland R., Brownell A.I., Bridges J.M., Blattner W.A., Gallo R.C. Adult T-cell lymphoma in Blacks from the West Indies. Lancet 1982; 1: 639–643
   PubMed Web of Science ®Google Scholar
• Gurtsevitch V., Senjuta N., Paviish O., Shih J., Pivnik A., Yakhina E., Stepina V., Kremenetskaya I., Syrtsev A. Clinical, morphological and virological features of an HTLV-I positive case of adult T-cell leukemia in a white man from Caucasus. Leuk Res 1993; 17(7)621–627
   PubMed Web of Science ®Google Scholar
• Cunningham D., Gilchrist N.G., Jack A., Dalgleish A.G., Soukop M., Lee F.D. T-lymphoma associated with HTLV-I outside the Caribbean and Japan. Lancet 1985; 337–338
   Google Scholar
• Kawano F., Yamaguchi K., Nishimura H., Tsuda H., Takatsuki K. Variation in clinical courses of adult T-cell leukemia. Cancer 1985; 55: 851–856
   PubMed Web of Science ®Google Scholar
• Yamaguchi K., Yul L.S., Oda T., Maeda Y., Ishii M., Fujita K., Kagiyama S., Nagai K., Suzuki H., Takatsuki K. Clinical consequences of 2′-deoxycoformycin therapy in patients with refractory adult T-cell leukemia. Leuk Res 1986; 10: 989–993
   PubMed Web of Science ®Google Scholar
• Lofters W., Campbell M., Gibbs N., Cheson B.D. 2′-deoxycoformycin therapy in adult T-cell leukemia/lymphoma. Cancer 1987; 60: 2605–2608
   PubMed Web of Science ®Google Scholar
• Lymphoma Study Group. Major prognostic factors of patients with adult T-cell leukemia-lymphoma: a cooperative study. Leuk Res 1991; 15: 81–90
   PubMed Web of Science ®Google Scholar
• Shimoyama M. Treatment of patients with adult T-cell leukemia-lymphoma: an overview. Gann Monograph Cancer Research 1992; 39: 43–46
   Google Scholar
• Tsukasaki K., Ikeda S., Murata K., Maeda T., Atogami S., Sohda H., Momita S., Jubashi T., Yamada Y., Mine M., Kamihira S., Tomonaga M. Characteristics of chemotherapy-induced clinical remission in long survivors with aggressive adult T-cell leukemia/lymphoma. Leuk Res 1993; 17: 157–166
   PubMed Web of Science ®Google Scholar
• Taguchi H., Kinoshito K., Takatsuki K., Tomonaga M., Araki K., Arima N., Ikeda S., Uozimi K., Kohno H., Kawano F., Kikuchi H., Takahashi H., Tamura K., Chiyoda S., Tsuda H., Nishimura H., Hosokawa T., Matsuzaki H., Momita S., Yamada O., Miyoshi I. An intensive chemotherapy of adult T-cell leukemia/lymphoma: CHOP followed by etoposide, vindesine, ranimustine, and mitoxantrone with granulocyte colony-stimulating factor-support. J AIDS Human Retroviral 1996; 12: 182–186
   PubMedGoogle Scholar
• Ljungman P., Lawler M., Asjo B., Bogdanovic G., Karlsson K., Malam C., McCann S.R., Ringden O., Gahrton G. Infection of donor lymphocytes with HTLV-I following allogeneic bone marrow transplantation for HTLV-I positive ATL. Br J Haem 1994; 88: 403–405
   PubMed Web of Science ®Google Scholar
• Shimoyama M., members of the Lymphoma Study Group. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukemia/lymphoma. Br J Haem 1991; 79: 428–437
   PubMed Web of Science ®Google Scholar
• Borg A., Liu Yin J.A., Johnson P.R.E., Tosswill J., Saunders M., Morris D. Successful treatment of HTLV-I-associated acute adult T-cell leukemia lymphoma by allogeneic bone marrow transplantation. Br J Haem 1996; 94: 713–715
   PubMed Web of Science ®Google Scholar
• Gill P.S., Harrington W., Kaplan M.H., Ribiero R.C., Bennett J.M., Liebman H.A., Bernstein-Singer M., Espina B.M., Cabral L., Allen S., Kornblau S., Pike M.C., Levine A.M. Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. NEJM 1995; 332: 1744–1748
   PubMed Web of Science ®Google Scholar
• J Hermine O., Bouscary D., Gessain A., Turlure P., Leblond FranckN., Buzyn-Veil A., Rio B., Macintyre E., Dreyfus F., Bazarbachi A. Treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa. NEJM 1995; 332: 1749–1751
   PubMed Web of Science ®Google Scholar
• Kaplan E.L., Meier P. Non parametric estimation from incomplete observations. Journal of the American Statistical Association 1958; 53: 457–481
   Web of Science ®Google Scholar
• Hoque S., Kelsey S., van der Walt J.D., Breuer J. Experience of human T-lymphotropic virus type I in an East London hospital. J Infection 1996; 32: 33–39
   PubMed Web of Science ®Google Scholar
• Brito-Babapulle F., Arya R., Griffiths T., Pagliuca A., Mufti G.J. BEAM regimen and G-CSF in HTLV-I-associated T-cell lymphoma. Lancet 1992; 339: 133–134
   PubMed Web of Science ®Google Scholar
• Matutes E., Catovsky D. Mature T-cell leukemias and leukemia/lymphoma syndromes. Leuk Lymphoma 1991; 4: 81–91
   PubMed Web of Science ®Google Scholar
• Shimomoto Y., Miyahara M., Yamada H., Shibata K., Matsuzaki M., Ono K. ATLL with multiple integrations of HTLV-I proviral DNA: differing clinical features are linked to varied proviral integration. Br J Haem 1996; 92: 632–638
   PubMed Web of Science ®Google Scholar
• Nagafuji K., Harada M., Teshima T., Eto T., Takamatsu Y., Okamura T., Murakawa M., Akashi K., Niho Y. Hematopoietic progenitor cells from patients with adult T-cell leukemia-lymphoma are not infected with human T-cell leukemia virus type I. Blood 1993; 82: 2823–2828
   PubMed Web of Science ®Google Scholar
• Suzumiya J., Marutsuka K., Nabeshima K., Nawa Y., Koono M., Tamura K., Kimura N., Hisano S., Tachibana N., Inoue S., Sumiyoshi A. Autopsy findings in 47 cases of adult T-cell leukemia/lymphoma in Miyazaki prefecture, Japan. Leuk Lymphoma 1993; 11: 281–286
   PubMed Web of Science ®Google Scholar
• Pagliuca A., Layton D.M., Mufti G.J. Hyperinfection with strongyloides after treatment of adult T-cell leukemia-lymphoma in an African immigrant. BMJ 1988; 297: 1456–1457
   PubMed Web of Science ®Google Scholar
• Taguchi H., Kobayashi M., Miyoshi I. Immunosuppression by HTLV-I infection. Lancet 1991; 337: 308–309
   Web of Science ®Google Scholar
• Tamura K., Makino S., Araki Y., Imamura T., Seita M. Recombinant interferon beta and gamma in the treatment of adult T-cell leukemia. Cancer 1987; 59: 1059–1062
   PubMed Web of Science ®Google Scholar
• Ezaki K., Hirano M., Ohno R., Yamada K., Naito K., Hirota Y., Shirakawa S., Kimura K. A combination trial of human lymphoblastoid interferon and bestrabucil (KM2210) for adult T-cell leukemia/lymphoma. Cancer 1991; 68: 695–698
   PubMed Web of Science ®Google Scholar
• Greene W.C., Leonard W.J., Depper J.M., Nelson D.L., Waldmann T.A. The human interleukin-2 receptor: normal and abnormal expression in T-cells and in leukemias induced by the human T-lymphotropic retroviruses. Ann Int Med 1986; 105: 560–572
   PubMed Web of Science ®Google Scholar
• Waldmann T.A., White J.D., Goldman C.K., Top L., Grant A., Bamford R., Roessler E., Horak I.D., Zaknoen S., Kasten-Sportes C., England R., Horak E., Mishra B., Dipre M., Hale P., Fleisher T.A., Junghaus R.P., Jaffe E.S., Nelson D.L. The interleukin-2 receptor: a target for monoclonal antibody treatment of human T-cell lymphotropic virus-Tinduced adult T-cell leukemia. Blood 1993; 82: 1701–1712
   PubMed Web of Science ®Google Scholar
• Pagliuca A., Pawson R., Mufti G.J. HTLV-I screening in Britain. BMJ 1995; 311: 1313–1314
   PubMed Web of Science ®Google Scholar